Related Articles
RICH1 is a novel key suppressor of isoproterenol‑ or angiotensin II‑induced cardiomyocyte hypertrophy
Role of microRNAs in cardiac development and disease (Review)
Rho GTPases as therapeutic targets in cancer (Review)
HMG-CoA reductase inhibitors (statins) as anticancer drugs (Review)
Signaling pathways regulated by Rho-like proteins